Chenzhang Shi
Overview
Explore the profile of Chenzhang Shi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
916
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huang J, Lu W, Zhao S, Cai Z, Li L, Hu Z, et al.
Redox Biol
. 2025 Feb;
80:103501.
PMID: 39919369
Skin fibrosis, characterized by uncontrolled secretion of extracellular matrix (ECM) proteins such as collagen, can lead to excessive scarring and compromised tissue function. Despite the widespread occurrence of fibrotic diseases,...
2.
Jia S, Huang J, Lu W, Miao Y, Huang K, Shi C, et al.
J Pharm Anal
. 2024 Aug;
14(7):100948.
PMID: 39109384
Skin flaps are frequently employed in plastic and reconstructive surgery to address tissue defects. However, their low survival rates remain a challenge, attributed to vascular crisis and necrosis. Despite numerous...
3.
Lu L, Liu C, Liu K, Shi C, Liu Z, Jiang X, et al.
Sci Rep
. 2023 Aug;
13(1):13216.
PMID: 37580432
Associations between leisure sedentary behavior (especially leisure screen time, LST) and irritable bowel syndrome (IBS) have been reported, but causality is unclear. Here, the two-sample Mendelian randomization was performed to...
4.
Li M, Wu S, Zhuang C, Shi C, Gu L, Wang P, et al.
Heliyon
. 2023 Jan;
9(1):e12515.
PMID: 36691542
Metabolic reprogramming is one of the essential features of tumor that may dramatically contribute to metastasis and collapse. The metabolic profiling is investigated on the patient derived tissue and cancer...
5.
Pan D, Liu D, Liang L, Shen T, Shi C, Qin H
Front Oncol
. 2022 Jun;
12:863392.
PMID: 35664730
Purpose: Programmed cell death protein 1 (PD-1) inhibitor plus apatinib is reported to be a promising strategy for advanced cancers. Moreover, a PD-1 inhibitor or apatinib exerts a certain efficacy...
6.
Jiang X, Shen T, Lu H, Shi C, Liu Z, Qin H, et al.
Oncol Rep
. 2019 Sep;
42(5):2117-2129.
PMID: 31545467
It has been reported that kruppel‑like factor 17 (KLF17) acts as a tumour suppressor in several tissues and cancer cells, however, the molecular roles, the underlying mechanisms and clinical significance...
7.
Shi C, Li H, Qu X, Huang L, Kong C, Qin H, et al.
Biomed Pharmacother
. 2018 Dec;
110:537-545.
PMID: 30530289
Microtubule-actin cross-linking factor-1 (ACF7, or MACF1) regulates cytoskeletal focal adhesion dynamics and migration in various tissues. High fat diet (HFD) induces gut microbiota dysbiosis and metabolic disorders, and increases intestinal...
8.
Pan C, Yan X, Li H, Huang L, Yin M, Yang Y, et al.
Oncotarget
. 2017 Oct;
8(40):68317-68328.
PMID: 28978119
Because patients with colorectal cancer (CRC) are usually diagnosed at an advanced stage and current serum tumor markers have limited diagnostic efficacy, there is an urgent need to identify reliable...
9.
Chen H, Xia Y, Zhu S, Yang J, Yao J, Di J, et al.
Mol Med Rep
. 2017 Aug;
16(5):5979-5985.
PMID: 28849048
The association between inflammatory bowel disease (IBD) and gut microbes has been widely investigated. Our previous study demonstrated that Lactobacillus plantarum LP‑Onlly (LP) applied as a probiotic altered the gut...
10.
Ma Y, Yue J, Zhang Y, Shi C, Odenwald M, Liang W, et al.
Nat Commun
. 2017 Jul;
8:16121.
PMID: 28695897
This corrects the article DOI: 10.1038/ncomms15375.